BI
ASND icon

Binnacle Investments’s Ascendis Pharma A/S ASND Stock Holding History

Binnacle Investments’s Portfolio ASND Stock Details ASND Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		$596 Hold
3
– – ﹤0.01% 830
2025
Q2 		$518 Hold
3
– – ﹤0.01% 769
2025
Q1 		$468 Buy
+3
New +$429 ﹤0.01% 708

Other funds holding ASND

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Binnacle Investments's ASND Position: Q3 2025 in Review

Binnacle Investments held its Ascendis Pharma A/S (ASND) position steady in Q3 2025 at 3 shares worth $596. The position accounts for ﹤0.01% of the portfolio, ranked #830.

Binnacle Investments first reported a position in ASND in Q1 2025 and has held it in 3 quarters since. 279 funds tracked by Wall St. Rank hold ASND as of Q3 2025.

  • Binnacle Investments held 3 shares of Ascendis Pharma A/S worth $596 as of Q3 2025.
  • Binnacle Investments left its Ascendis Pharma A/S share count unchanged in Q3 2025.
  • Ascendis Pharma A/S made up ﹤0.01% of Binnacle Investments's portfolio in Q3 2025, its #830 holding.
  • Binnacle Investments first reported a position in Ascendis Pharma A/S in Q1 2025 and has held it in 3 quarters since.
  • 279 funds tracked by Wall St. Rank held Ascendis Pharma A/S as of Q3 2025.

Based on Binnacle Investments's 13F filing for Q3 2025, filed 14 Nov 2025.